Paper6969578
Purification and biochemical properties of beta-lactamase produced by Proteus rettgeri.
Matsuura M and 3 others. Antimicrob Agents Chemother, 1980. Cited by 24 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Purification and biochemical properties of beta-lactamase produced by Proteus rettgeri. Papers, record 6969578. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6969578
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Proteus | Major topic |
| beta-Lactamases | Major topic |
| Anti-Bacterial Agents | |
| Bacterial Proteins | |
| Drug Resistance, Microbial | |
| Molecular Weight |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,304,281 | Drug resistance of enteric bacteria. XIV. Comparison of beta-lactamases in gram-negative rod bacteria resistant to alpha-aminobenzylpenicillin. | Jpn J Microbiol | 1968 | https://conductscience.org/library/papers/5304281 | PubMed |
| 2 | 5,806,584 | The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. | J Biol Chem | 1969 | https://conductscience.org/library/papers/5806584 | PubMed |
| 3 | 4,581,138 | The beta-lactamases of gram-negative bacteria and their possible physiological role. | Adv Microb Physiol | 1973 | https://conductscience.org/library/papers/4581138 | PubMed |
| 4 | 4,368,359 | A spectrophotometric assay of beta-lactamase action on penicillins. | Biochem J | 1974 | https://conductscience.org/library/papers/4368359 | PubMed |
| 5 | 4,497,004 | Beta-lactamase formation and resistance of Proteus morganii to various penicillins and cephalosporins. | Jpn J Microbiol | 1974 | https://conductscience.org/library/papers/4497004 | PubMed |
| 6 | 1,259,407 | Cefuroxime, a new cephalosporin antibiotic: activity in vitro. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/1259407 | PubMed |
| 7 | 783,110 | The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics. | J Antimicrob Chemother | 1976 | https://conductscience.org/library/papers/783110 | PubMed |
| 8 | 576,821 | Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin. | Arzneimittelforschung | 1977 | https://conductscience.org/library/papers/576821 | PubMed |
| 9 | 879,738 | Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/879738 | PubMed |
| 10 | 70,426 | Purification and properties of beta-lactamase from Proteus morganii. | J Bacteriol | 1977 | https://conductscience.org/library/papers/70426 | PubMed |
| 11 | 417,670 | SCE-129, antipseudomonal cephalosporin: in vitro and in vivo antibacterial activities. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/417670 | PubMed |
| 12 | 309,306 | CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/309306 | PubMed |
| 13 | 718,154 | SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/718154 | PubMed |
| 14 | 314,774 | Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/314774 | PubMed |
| 15 | 316,988 | In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/316988 | PubMed |
| 16 | 6,968,539 | Purification and properties of a new beta-lactamase from Pseudomonas cepacia. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6968539 | PubMed |
| 18 | 15,828,189 | Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/15828189 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 19,136,439 | AmpC beta-lactamases. | Clin Microbiol Rev | 2009 | https://conductscience.org/library/papers/19136439 | PubMed |
| 7,574,506 | A functional classification scheme for beta-lactamases and its correlation with molecular structure. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7574506 | PubMed |
| 6,808,912 | Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6808912 | PubMed |
| 6,303,743 | Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use. | Drugs | 1983 | https://conductscience.org/library/papers/6303743 | PubMed |
| 6,269,489 | Immunological properties of beta-lactamases that hydrolyze cefuroxime and cefotaxime. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6269489 | PubMed |
| 6,100,421 | In vitro antibacterial activity of E-0702, a new semisynthetic cephalosporin. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6100421 | PubMed |
| 3,879,159 | In vitro antibacterial activity of Sch 34343 and its stability to beta-lactamases and renal dehydropeptidase 1. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/3879159 | PubMed |
| 3,499,115 | In vitro and in vivo antibacterial activities of T-2588, a new oral cephalosporin, compared with those of other oral beta-lactam antibiotics. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3499115 | PubMed |
| 3,310,868 | In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3310868 | PubMed |
| 3,264,132 | In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/3264132 | PubMed |
| 3,034,144 | Identification of porins in outer membrane of Proteus, Morganella, and Providencia spp. and their role in outer membrane permeation of beta-lactams. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3034144 | PubMed |
| 2,658,780 | Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2658780 | PubMed |
| 2,475,102 | Purification of a class C A-type beta-lactamase from a derepressed strain of Enterobacter cloacae. Comparison of the wild-type and mutant enzyme with those from strains P99, 208 and GN7471. | Biochem J | 1989 | https://conductscience.org/library/papers/2475102 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6969578
GET https://conductscience.org/api/papers/v1/6969578/authors